Zacks Investment Research
19 Jun 2026, 16:41 UTC · 15w ago
LSEGY vs. CME: Which Stock Is the Better Value Option?
Impact · against what's priced in
LSEGY appears marginally more attractive due to positive earnings estimate revisions and superior value metrics relative to CME. CME remains neutral as its current valuation and analyst outlook do not provide a catalyst for price movement.
- CME−0.10
No priced-in read yet
- In context
The company holds a neutral Zacks Rank of #3 and poor relative value metrics (Value grade 'D') compared to LSEGY.
Read from the article alone
- Actual

Search tags




